Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-Cell – Jewish Business News
|
Novartis In Advanced Talks to Acquire Israeli Stem Cell Developer Gamida-Cell
Jewish Business News Stem cell therapies developer Gamida-Cell Ltd. has received an acquisition offer from an international pharma company, Novartis AG (NYSE:NVS; LSE: NOV; SWX: NOVZ). Elbit Medical Technologies, which has a 30.8 percent share in Gamida, said in a … Israel’s Gamida Cell gets buyout offer from unnamed drugmakerReuters UK |
